Pangua-Irigaray, C. (., Espuelas, S. (., Martinez-Oharriz, C. (., Vizmanos-Pérez, J. (. L., & Irache-Garreta, J. (. M. (2023). Mucus‑penetrating and permeation enhancer albumin‑based nanoparticles for oral delivery of macromolecules: Application to bevacizumab.
Citación estilo ChicagoPangua-Irigaray, C. (Cristina)|||/items/05a595d9-7d04-44ba-a19a-8c619265fb3d, S. (Socorro)|||/items/b57c05de-0bc4-4fcf-ae1e-c9b2fb92964c Espuelas, C. (Cristina)|||/items/e9c18b09-044e-4df2-9269-5875b2c8e1ef Martinez-Oharriz, J.L. (José Luis)|||/items/0b2056b2-7080-40ae-aa7a-69961545fc6e Vizmanos-Pérez, y J.M. (Juan Manuel)|||/items/c7cbbe9e-faeb-47e1-b7e8-2d956ca50173 Irache-Garreta. Mucus‑penetrating and Permeation Enhancer Albumin‑based Nanoparticles for Oral Delivery of Macromolecules: Application to Bevacizumab. 2023.
Cita MLAPangua-Irigaray, C. (Cristina)|||/items/05a595d9-7d04-44ba-a19a-8c619265fb3d, et al. Mucus‑penetrating and Permeation Enhancer Albumin‑based Nanoparticles for Oral Delivery of Macromolecules: Application to Bevacizumab. 2023.